Editas Medicine Inc (EDIT)

Aug 14, 2025

Editas Medicine Inc. Rebound Backed by Sentiment Shift2025 Price Action Summary & Consistent Income Trade Recommendations - sundaytimes.kr

Aug 14, 2025

Aug 14, 2025

Editas Medicine Inc. Pullback Analyzed — Is It Time to Exit2025 Buyback Activity & Growth Oriented Trade Recommendations - thegnnews.com

Aug 14, 2025

Aug 14, 2025

Editas Medicine Inc. Faces Significant Business Risks: Key Factors for Investors to Watch - TipRanks

Aug 14, 2025

Aug 13, 2025

Editas Medicine Reports Q2 2025 Progress and Financials - TipRanks

Aug 13, 2025

Aug 13, 2025

Editas Medicine’s SWOT analysis: gene editing stock faces challenges, opportunities - Investing.com

Aug 13, 2025

Aug 13, 2025

A Quick Look at Today's Ratings for Editas Medicine(EDIT.US), With a Forecast Between $3 to $6 - 富途牛牛

Aug 13, 2025

Aug 13, 2025

Editas Medicine Surges 34% on Q2 Momentum and Strategic Milestones – What’s Fueling the Biotech Rally? - AInvest

Aug 13, 2025

Aug 13, 2025

Can Editas Medicine Inc. Regain Momentum After BreakdownQuarterly Profit Review & Precise Buy Zone Identification - 선데이타임즈

Aug 13, 2025

Aug 13, 2025

Baird raises Editas Medicine stock price target to $6 on pipeline progress - Investing.com Nigeria

Aug 13, 2025

Aug 13, 2025

Editas Medicine (EDIT) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 13, 2025

Aug 13, 2025

Editas: Q2 Earnings Snapshot - New Haven Register

Aug 13, 2025

Aug 13, 2025

Editas Medicine 2025 Q2 Earnings Narrows Losses Amid Revenue Surge - AInvest

Aug 13, 2025

Aug 12, 2025

Editas Medicine's Q2 Performance: Assessing Progress Amid Financial Challenges - AInvest

Aug 12, 2025

Aug 12, 2025

Editas Medicine Misses Expectations But Stays Focused On The Future - Finimize

Aug 12, 2025

Aug 12, 2025

Editas Medicine earnings missed by $0.23, revenue topped estimates - Investing.com South Africa

Aug 12, 2025

Aug 12, 2025

Editas Medicine Inc Q2 2025 Earnings: Revenue Soars to $3.6M, Beating Estimates; EPS Misses at -$0.63 - GuruFocus

Aug 12, 2025

Aug 12, 2025

Editas Medicine posts Q2 net loss of $53.2 mln - MarketScreener

Aug 12, 2025

Aug 12, 2025

Editas Medicine Q2 2025: On track to file IND by mid-2026, proof-of-concept by year-end. - AInvest

Aug 12, 2025

Aug 12, 2025

Editas Medicine Announces Second Quarter 2025 Results and Business Updates - GlobeNewswire

Aug 12, 2025

Aug 12, 2025

Editas Medicine Reports Q2 2025 Results, Advances Gene Editing Programs - AInvest

Aug 12, 2025

Aug 12, 2025

Editas Medicine narrows losses as Bristol Myers Squibb partnership hits key milestone - Stock Titan

Aug 12, 2025

Aug 10, 2025

Editas Medicine, Inc. (NASDAQ:EDIT) Shares Bought by XTX Topco Ltd - MarketBeat

Aug 10, 2025

Aug 09, 2025

Published on: 2025-08-09 06:19:25 - Newser

Aug 09, 2025

Aug 09, 2025

Quantitative breakdown of Editas Medicine Inc. recent moveInvestment Timeline and ROI Summary Report - Newser

Aug 09, 2025

Aug 09, 2025

Analysts Set Editas Medicine, Inc. (NASDAQ:EDIT) PT at $4.70 - MarketBeat

Aug 09, 2025

Aug 09, 2025

Editas Medicine, Inc. (NASDAQ:EDIT) EVP Linda Burkly Sells 5,121 Shares - MarketBeat

Aug 09, 2025

Aug 08, 2025

What makes Editas Medicine Inc. stock price move sharplyExit Strategy Guide With Risk Control Plan - Newser

Aug 08, 2025

Aug 08, 2025

Editas Medicine SVP Parison Amy Sells 679 Shares at $2.58/Share. - AInvest

Aug 08, 2025

Aug 06, 2025

Evaluating Editas Medicine Inc. with trendline analysisAI Stock Movement Forecast with Accuracy - Newser

Aug 06, 2025

Aug 06, 2025

How Interest Rate Changes Impact Editas Medicine Inc. Stock PerformanceAI Entry Timing Prediction for Swing Traders - Newser

Aug 06, 2025

Aug 06, 2025

Editas Medicine, Inc. (NASDAQ:EDIT) Shares Sold by Bank of New York Mellon Corp - Defense World

Aug 06, 2025

Aug 05, 2025

Can you recover from losses in Editas Medicine Inc.Free Early Breakout Entry Point Notifications - Newser

Aug 05, 2025

Aug 04, 2025

Editas Medicine EVP Sells Shares to Meet Tax Obligations - TradingView

Aug 04, 2025

Aug 04, 2025

Trendlines Converge — Decision Point for Editas Medicine Inc.Real Profit Trade Plan Suggestions Shared Widely - beatles.ru

Aug 04, 2025

Aug 03, 2025

Editas Medicine (EDIT) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Aug 03, 2025

Aug 03, 2025

Why is Editas Medicine Inc. stock attracting strong analyst attentionAccess powerful market insights for free - Jammu Links News

Aug 03, 2025

Aug 03, 2025

How strong is Editas Medicine Inc. company’s balance sheetConsistently superior profits - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are analysts’ price targets for Editas Medicine Inc. in the next 12 monthsUnlock powerful trading alerts for success - Jammu Links News

Aug 03, 2025

Aug 03, 2025

When is Editas Medicine Inc. stock expected to show significant growthGet alerts on top growth stocks daily - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What institutional investors are buying Editas Medicine Inc. stockBuild wealth faster with disciplined trading - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Should I hold or sell Editas Medicine Inc. stock in 2025Maximize your portfolio’s earning power - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Is Editas Medicine Inc. a growth stock or a value stockHigh-profit stock alerts - Jammu Links News

Aug 03, 2025

Aug 03, 2025

Cwm LLC Has $55,000 Stake in Editas Medicine, Inc. (NASDAQ:EDIT) - Defense World

Aug 03, 2025

Aug 03, 2025

What is Editas Medicine Inc. company’s growth strategyTriple-digit profit margins - Jammu Links News

Aug 03, 2025

Aug 03, 2025

What are the technical indicators suggesting about Editas Medicine Inc.Invest smarter with actionable trading signals - Jammu Links News

Aug 03, 2025

Aug 02, 2025

Is Editas Medicine Inc. stock overvalued or undervaluedAchieve consistent double-digit growth rates - Jammu Links News

Aug 02, 2025

Aug 02, 2025

What catalysts could drive Editas Medicine Inc. stock higher in 2025High-yield trading alerts - Jammu Links News

Aug 02, 2025